News

MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...
The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...
Summit Therapeutics Inc.'s valuation hinges on ivonescimab's potential, yet the data, competition, and regulatory issues ...
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
The highest-paying dividend stocks in the Dow Jones Industrial Average right now are Verizon Communications (NYSE: VZ), ...
President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...
MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...
Thousands of women battling an advanced form of womb cancer have been offered renewed hope after a new treatment was approved for widespread use on the NHS. At such a critical moment in US history, we ...
Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...